Open access
1,896
Views
20
CrossRef citations to date
0
Altmetric
Original Articles
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies
Nathalie van den TempelDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Hanny OdijkDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Netteke van HoltheDepartment of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; View further author information
, Kishan NaipalDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Anja RaamsDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Berina EppinkDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Dik C. van GentDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Jose HardilloDepartment of Otolaryngology and Head and Neck Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Gerda M. VerduijnDepartment of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; View further author information
, Jan C. DroogerDepartment of Medical Oncology, Ikazia Hospital, Rotterdam, The Netherlands; View further author information
, Gerard C. van RhoonDepartment of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; View further author information
, Dineke (H.) P.M. SmedtsDepartment of Gynaecological Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Helena C. van DoornDepartment of Gynaecological Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands; View further author information
, Joost L. BoormansDepartment of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; View further author information
, Agnes JagerDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The NetherlandsView further author information
, Martine FranckenaDepartment of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; View further author information
& Roland KanaarDepartment of Molecular Genetics, Cancer Genomics Centre Netherlands Erasmus University Medical Centre, Rotterdam, The Netherlands; Correspondence[email protected]
View further author information
show allView further author information
Pages 407-414
|
Received 10 May 2017, Accepted 09 Jul 2017, Published online: 31 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.